Latest Tissue plasminogen activator Stories
The use of clot-busting drugs to treat acute ischemic stroke increased from 2005 through 2009 â€” but is still low.
A new treatment that treats a subset of stroke patients by combining minimally invasive surgery, an imaging technique likened to "GPS for the brain," and the clot-busting drug t-PA appears to be safe and effective.
Strokes are not typically thought of as a childhood health issue, but Baylor College of Medicine experts warn that they do occur in children and can result in significant long-lasting effects.
Approximately 14 percent of all strokes occur during sleep, preventing many from getting clot-busting treatment.
Approximately 14 percent of all strokes occur during sleep, preventing many from getting clot-busting treatment, according to a study.
CENTENNIAL, Colo., May 2, 2011 /PRNewswire/ -- Bailey Carlson, 17, appears to live a typical teenage life. She is focused on school, friends and sleepovers.
Dr. George Rappardâ€™s Site is cleared to begin enrolling patients in new study. This clinical trial is the first U.S.
DALLAS, March 15, 2011 /PRNewswire/ -- Children's Medical Center Dallas (Children's) http://childrens.com is launching a critical stroke initiative to diagnose and treat strokes in children.
RESEARCH TRIANGLE PARK, N.C., March 3, 2011 /PRNewswire/ -- Talecris Biotherapeutics, Inc. (TLCR) announced today that it has been granted orphan drug designation by the European Commission for the development of Plasmin (human) to treat acute peripheral arterial occlusion (aPAO).
Whether or not you're a fan of Indian, Southeast Asian or Middle Eastern food, stroke researchers at Cedars-Sinai Medical Center say you might become fond of one of their key spices.